Ichor Biologics (New York) Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Ichor Biologics (New York) General Information
Description
Developer of human antibody-based treatments designed for infectious diseases. The company engages in antibody discovery, plasma-derived product development, therapeutic research, antibody characterization, laboratory analysis, manufacturing, and research platform technologies, enabling healthcare organizations to access biological therapeutics, support infectious disease treatment, and advance biomedical research.
Contact Information
Website
www.ichorbiologics.comCorporate Office
- 423 West 127th Street
- New York, NY 10027
- United States
Corporate Office
- 423 West 127th Street
- New York, NY 10027
- United States
Ichor Biologics (New York) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Nov-2024 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Feb-2020 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-May-2019 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Mar-2017 | $250K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Jan-2016 | Completed | Pre-Clinical Trials |
Ichor Biologics (New York) Patents
Ichor Biologics (New York) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12054536-B2 | Antibodies to andes hantavirus, and methods for using same | Active | 22-Mar-2017 | ||
| US-20200087381-A1 | Antibodies to andes hantavirus, and methods for using same | Active | 22-Mar-2017 | ||
| US-20220298229-A1 | Antibodies to andes hantavirus, and methods for using same | Active | 22-Mar-2017 | ||
| US-20240368255-A1 | Antibodies to andes hantavirus, and methods for using same | Pending | 22-Mar-2017 | ||
| WO-2018175531-A2 | Antibodies to andes hantavirus, and methods for using same | Inactive | 22-Mar-2017 | C07K16/10 |
Ichor Biologics (New York) Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harlem Biospace | Accelerator/Incubator | |||
| National Institutes of Health | Government | |||
| FONDEF | Government | |||
| Entrepreneurship Lab Bio & Health Tech NYC | Accelerator/Incubator |
Ichor Biologics (New York) FAQs
-
When was Ichor Biologics (New York) founded?
Ichor Biologics (New York) was founded in 2013.
-
Where is Ichor Biologics (New York) headquartered?
Ichor Biologics (New York) is headquartered in New York, NY.
-
What industry is Ichor Biologics (New York) in?
Ichor Biologics (New York)’s primary industry is Drug Discovery.
-
Is Ichor Biologics (New York) a private or public company?
Ichor Biologics (New York) is a Private company.
-
What is Ichor Biologics (New York)’s current revenue?
The current revenue for Ichor Biologics (New York) is .
-
Who are Ichor Biologics (New York)’s investors?
Harlem Biospace, National Institutes of Health, FONDEF, and Entrepreneurship Lab Bio & Health Tech NYC have invested in Ichor Biologics (New York).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process